BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15298533)

  • 1. Clinical pharmacist intervention in a primary care medical group reduces financial losses.
    Curtiss FR
    J Manag Care Pharm; 2004; 10(4):355. PubMed ID: 15298533
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact on drug costs and utilization of a clinical pharmacist in a multisite primary care medical group.
    Walker S; Willey CW
    J Manag Care Pharm; 2004; 10(4):345-54. PubMed ID: 15298532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration Strategies of Pharmacists in Primary Care-Based Accountable Care Organizations: A Report from the Accountable Care Organization Research Network, Services, and Education.
    Joseph T; Hale GM; Eltaki SM; Prados Y; Jones R; Seamon MJ; Moreau C; Gernant SA
    J Manag Care Spec Pharm; 2017 May; 23(5):541-548. PubMed ID: 28448780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care Pharmacist Services Align With Payment Reform and Provider "Joy of Practice".
    Smith M
    Ann Pharmacother; 2019 Mar; 53(3):311-315. PubMed ID: 30303028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006.
    Guillaume L; Cooper R; Avery A; Mitchell S; Ward P; Anderson C; Bissell P; Hutchinson A; James V; Lymn J; McIntosh A; Murphy E; Ratcliffe J
    J Clin Pharm Ther; 2008 Feb; 33(1):11-6. PubMed ID: 18211611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial performance and reimbursement of pharmacist-led chronic care management.
    Martin R; Tram K; Le L; Simmons C
    Am J Health Syst Pharm; 2020 Nov; 77(23):1973-1979. PubMed ID: 32995845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sustainable business model for comprehensive medication management in a patient-centered medical home.
    Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
    J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel synchronized visit model as financial justification for clinic-embedded pharmacists.
    Bowers BL; Rowe JM; Fox LM; VanDeWege C; Billings S
    Am J Health Syst Pharm; 2019 Dec; 76(24):2080-2086. PubMed ID: 31789350
    [No Abstract]   [Full Text] [Related]  

  • 10. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
    Bagwell A; Kelley T; Carver A; Lee JB; Newman B
    J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
    Tate ML; Hopper S; Bergeron SP
    J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates to the compensation plan for pharmacy services in Alberta, Canada.
    Breault RR; Schindel TJ; Whissell JG; Hughes CA
    J Am Pharm Assoc (2003); 2018; 58(6):597-598. PubMed ID: 30217385
    [No Abstract]   [Full Text] [Related]  

  • 14. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of pharmaceutical care: can the profession do anything?
    Hopefl AW
    Ann Pharmacother; 1992 Dec; 26(12):1585-8. PubMed ID: 1482817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
    Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD
    J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic effects of pharmacists on health outcomes in the United States: A systematic review.
    Chisholm-Burns MA; Graff Zivin JS; Lee JK; Spivey CA; Slack M; Herrier RN; Hall-Lipsy E; Abraham I; Palmer J
    Am J Health Syst Pharm; 2010 Oct; 67(19):1624-34. PubMed ID: 20852164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Clinical Pharmacists on Readmission Rates of Heart Failure Patients in the Accountable Care Environment.
    Schumacher C; Moaddab G; Colbert M; Kliethermes MA
    J Manag Care Spec Pharm; 2018 Aug; 24(8):795-799. PubMed ID: 30058987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacists in general practice: an initial evaluation of activity in one English primary care organisation.
    Bush J; Langley CA; Jenkins D; Johal J; Huckerby C
    Int J Pharm Pract; 2018 Dec; 26(6):501-506. PubMed ID: 29280513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.